Guinea Pig - Scientific Research

Scientific Research

The use of guinea pigs in scientific experimentation dates back at least to the 17th century, when the Italian biologists Marcello Malpighi and Carlo Fracassati conducted vivisections of guinea pigs in their examinations of anatomic structures. In 1780, Antoine Lavoisier used a guinea pig in his experiments with the calorimeter, a device used to measure heat production. The heat from the guinea pig's respiration melted snow surrounding the calorimeter, showing that respiratory gas exchange is a combustion, similar to a candle burning. Guinea pigs played a major role in the establishment of germ theory in the late 19th century, through the experiments of Louis Pasteur, Émile Roux, and Robert Koch. Guinea pigs have been launched into orbital space-flight several times, first by the USSR on the Sputnik 9 biosatellite of March 9, 1961 – with a successful recovery. China also launched and recovered a biosatellite in 1990 which included guinea pigs as passengers.

In English, the term guinea pig is commonly used as a metaphor for a subject of scientific experimentation, or any experiment or test in modern times. This dates back to the early 20th century; the Oxford English Dictionary notes its first usage in this capacity in 1913. In 1933, Consumers Research founders F. J. Schlink and Arthur Kallet wrote a book entitled 100,000,000 Guinea Pigs, extending the metaphor to consumer society. The book became a national bestseller in the United States, thus further popularizing the term, and spurred the growth of the consumer protection movement. The negative connotation of the term was later employed in the novel The Guinea Pigs by Czech author Ludvík Vaculík as an allegory for Soviet totalitarianism.

Guinea pigs were popular laboratory animals until the later 20th century; about 2.5 million guinea pigs were used annually in the U.S. for research in the 1960s, but that total decreased to about 375,000 by the mid-1990s. As of 2007, they constitute approximately 2% of the current total of laboratory animals. In the past they were widely used to standardize vaccines and antiviral agents; they were also often employed in studies on the production of antibodies in response to extreme allergic reactions, or anaphylaxis. Less common uses included research in pharmacology and irradiation. Since the middle 20th century, they have been replaced in laboratory contexts primarily by mice and rats. This is in part because research into the genetics of guinea pigs has lagged behind that of other rodents, although geneticists W. E. Castle and Sewall Wright made a number of contributions to this area of study, especially regarding coat color. In 2004, the U.S.'s National Human Genome Research Institute announced plans to sequence the genome of the domestic guinea pig.

The guinea pig was most extensively implemented in research and diagnosis of infectious diseases. Common uses included identification of brucellosis, Chagas disease, cholera, diphtheria, foot-and-mouth disease, glanders, Q fever, Rocky Mountain spotted fever, and various strains of typhus. They are still frequently used to diagnose tuberculosis, since they are easily infected by human tuberculosis bacteria. Because guinea pigs are one of the few animals which, like humans, cannot synthesize vitamin C but must obtain it from their diet, they are ideal for researching scurvy. From the accidental discovery in 1907 that scurvy could be induced in guinea pigs, to their use to prove the chemical structure of the "ascorbutic factor" in 1932, the guinea pig model proved a crucial part of vitamin C research.

Complement, an important component for serology, was first isolated from the blood of the guinea pig. Guinea pigs have an unusual insulin mutation, and are a suitable species for the generation of anti-insulin antibodies. Present at a level 10 times that found in other mammals, the insulin in guinea pigs may be important in growth regulation, a role usually played by growth hormone. Additionally, guinea pigs have been identified as model organisms for the study of juvenile diabetes and, because of the frequency of pregnancy toxemia, of pre-eclampsia in human females.

Guinea pig strains used in scientific research are primarily outbred strains. Aside from the common American or English stock, the two main outbred strains in laboratory use are the Hartley and Dunkin-Hartley; these English strains are albino, although pigmented strains are also available. Inbred strains are less common and are usually used for very specific research, such as immune system molecular biology. Of the inbred strains that have been created, the two that are still used with any frequency are, following Sewall Wright's designations, "Strain 2" and "Strain 13".

Hairless breeds of guinea pigs have been used in scientific research since the 1980s, particularly for dermatological studies. A hairless and immunodeficient breed was the result of a spontaneous genetic mutation in inbred laboratory strains from the Hartley stock at the Eastman Kodak Company in 1979. An immunocompetent hairless breed was also identified by the Institute Armand Frappier in 1978, and Charles River Laboratories has reproduced this breed for research since 1982. Cavy fanciers then began acquiring hairless breeds, and the pet hairless varieties are referred to as "skinny pigs".